Prognostic implications of myocardial contractile reserve in patients with ischemic cardiomyopathy

Echocardiography

Volumn 17, Issue 1, 2000, Pages 61-67

  Galatro, Kathleen ^a   Chaudhry, Farooq A ^a  

^a HAHNEMANN UNIVERSITY HOSPITAL   (United States)

Author keywords

Left ventricular dysfunction; Myocardial viability; Prognosis

Indexed keywords

ARTICLE; CARDIOMYOPATHY; CELL VIABILITY; DISEASE SEVERITY; EXERCISE TEST; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILITY; HUMAN; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033954579     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2000.tb00996.x     Document Type: Article

References (35)

1. 1. Hammermeister K, DeRouen T, Dodge H: Variables predictive of survival in patients with coronary disease: Selection by univariate and multivariate analysis from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation 1979;59:421-430.
2. 2. Braunwald E, Kloner R: The stunned myocardium: Prolonged, post ischemic ventricular dysfunction. Circulation 1982;66:1146-1149.
3. 3. Bolli R: Mechanism of myocardial "stunning." Circulation 1990;82:723-738.
4. 4. Schelbert H: Metabolic imaging to assess myocardial viability. J Nucl Med 1994;35(suppl I): 8S-14S.
5. 5. Schelbert H, Buxton D. Insights into coronary artery disease gained from metabolic imaging. Circulation 1988;78:496-505.
6. 6. Bonow R, Berman D, Gibbons R, et al:Cardiac positron emission tomography: A report for health professionals from the Committee on Advanced Cardiac Imaging and Technology of the Council on Clinical Cardiology, American Heart Association. Circulation 1991;84:447-454.
7. 7. Iskandrian A, Hakki A, Kane S, et al: Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular funcion after coronary arterial bypass grafting. Am J Cardiol 1983;51:1312-1316.
8. 8. Berger B, Watson D, Burwell L, et al: Redistribution of thallium at rest in patients with stable and unstable angina and the effect of coronary artery bypass surgery. Circulation 1979; 60:1114-1125.
9. 9. Ohtani H, Tamaki N, Yonekura Y, et al: Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990;66:394-399.
10. 10. Kayden D, Sigal S, Soufer R, et al: Thallium-201 for assessment of myocardial viability: Quantitative comparison of 24-hour redistribution imaging with imaging after reinjection at rest. J Am Coll Cardiol 1991;18:1480-1486.
11. 11. Dilsizian V, Rocco T, Freedman N, et al: Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-146.
12. 12. Pierard L, De Lansheere C, Berthe C, et al: Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography. J Am Coll Cardiol 1990; 15:1021-1031.
13. 13. Afridi I, Kleiman N, Raizner A, et al: Dobutamine echocardiography in myocardial hibernation-optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-670.
14. 14. Perrone-Filardi P, Pace L, Prastaro M, et al: Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995; 91:2556-2565.
15. 15. Cigarroa C, DeFilippi C, Brickner E, et al: Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993;88:430-436.
16. 16. La Canna G, Alfiere O, Giubbini R, et al: Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:617-626.
17. 17. Charney R, Swinger M, Cohen M, et al: Dobutamine echocardiography predicts recovery of hibernating myocardium following coronary revascularization. J Am Coll Cardiol 1992;19: 176A. Abstract.
18. 18. Sehgal R, Lambert K, Saham G, et al: Prediction of viable myocardium by dobutamine echocardiography in patients with chronic left ventricular dysfunction. Clin Res 1993;41:641A.
19. 19. Cusick D, Aliwada G, Fredericksen J, et al: Dobutamine stress echocardiography can predict improvement in left ventricular ejection fraction after revascularization. J Am Coll Cardiol 1996;27:99A.
20. 20. Sabia P, Powers E, Ragosta M, et al: An association between collateral blood flow and myocardial viability with recent myocardial infarction. N Engl J Med 1992;327:1825-1831.
21. 21. Hendel R, Chaudhry FA, Bonow RO: Myocardial viability. Curr Probl Cardiol 1996;21:145-224.
22. 22. Arnese M, Cornel J, Salustri A, et al: Prediction of improvement of regional left ventricular function after surgical revascularization: A comparison of low-dose dobutamine echocardiography with thallium-201 single-photon emission computed tomography. Circulation 1995; 91:990-998.
23. 23. Vardi G, Ramani K, Aliwadi G, et al: Prognostic value of dobutamine stress echocardiography in patients with ischemic and nonischemic cardiomyopathy. J Am Soc Echo 1996;9:402L.
24. 24. Marcovitz PA, Shayna V, Horn RA, et al: Value of dobutamine stress echocardiography in determining the prognosis of patients with known or suspected coronary artery disease. Am J Cardiol 1996;78:404-408.
25. 25. Afridi I, Grayburn PA, Panza JA, et al: Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 1998; 32:921-926.
26. 26. Meluzin J, Cerny J, Frelich M, et al: Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study. J Am Coll Cardiol 1009;32:912-920.
27. 27. Picano E, Sicari R, Landi P, et al: Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: A dobutamine stress echocardiographic study. Circulation 1998;98: 1078-1084.
28. 28. Carlos ME, Smart SC, Wynsen JC, et al: Dobutamine stress echocardiography for risk stratification after myocardial infarction. Circulation 1997;95:1402-1410.
29. 29. Rahimtoola S: The hibernating myocardium. Am Heart J 1989;117:211-220.
30. 30. Ferrari R, Ferrari F, Benigno M, et al: Hibernating myocardium: Its pathophysiology and clinical role. Mol Cell Biochem 1998;186:195-199.
31. 31. Camici PG, Rimoldi O: Blood flow in myocardial hibernation. Curr Opin Cardiol 1998;13: 409-414.
32. 32. Mertes H, Sawada G, Ryan T, et al: Symptoms associated with dobutamine stress echocardiography: experience in 1118 patients. Circulation 1993;88:15-19.
33. 33. Singh K, Tauke J, Bonow R, et al: Safety of dobutamine stress echocardiography in patients with severe left ventricular dysfunction. Clin Res 1994;42:3508A.
34. 34. Cusick D, Aliwake G, Tauke J, et al: Presence of left ventricular apical thrombus predicts lack of myocardial viability: A dobutamine stress echocardiographic study. J Am Coll Cardiol 1996;27:369A.
35. 35. Afridi I, Qureshi U, Kopelen HA, et al: Serial changes in response of hibernating myocardium to inotropic stimulation after revascularization: A dobutamine echocardiographic study. J Am Coll Cardiol 1997;30:1233-1240.